أفضل بودكاسات 340B (2024)

1
Ep 53 | J&J 340B Rebate Model Follow-Up Discussion 52:59

5d ago52:59

52:59

In this episode, Greg and Rob catch up on developments surrounding the J&J 340B rebate proposal, including HRSA’s response. They’ll address some outstanding questions from the recent SpendMend webinar on the topic. In the intro, they recap some updates regarding contract pharmacy litigation and thoughts on how DSCSA and product serialization data m…

1
Introducing the Inside 340B Report Editorial Team 20:48

5d ago20:48

20:48

Episode 1: Introducing the Inside 340B Report Editorial Team Welcome to the very first episode of the Inside 340B Report podcast! In this debut episode, host Ted Slafsky, publisher and CEO of 340B Report, introduces listeners to the dynamic editorial team behind the show, Shannon Young, Will Newton, and Bella Czajkowski, as they share their backgro…

1
How a 340B Direct Savings Plan Works for Hospitals 15:18

19d ago15:18

15:18

The 340B drug pricing program is designed to give hospitals the flexibility to use their savings toward the types of patient care and support that their communities need the most. How does that work for hospitals that decide to use their access to 340B to provide the discounts directly to patients who cannot afford their drugs? Paul Orth, 340B prog…

1
EP448 (Part 2): 340B: Why Employers Should Probably Care About What’s Happening Here, With Shawn Gremminger 25:39

23d ago25:39

25:39

Maybe you’ve already caught Part 1 of my conversation with Shawn Gremminger, and if so, you're ahead of the game. But if not, no worries—here's the deal: I decided to split this deep dive into the 340B program with Shawn into two parts. So, feel free to jump into one or both—it’s totally up to you. To Read The Full Article Including Links Mentioned…

1
EP451: Hey, Let’s Not Talk About Artificial Intelligence, With Spencer Dorn, MD, MPH, MHA 12:39

2d ago12:39

12:39

Before we kick in to the show today, I just want to make two points. Here’s the first point. Together, we can do it. No one said transforming healthcare and elevating patients over profits would be easy. And it is not. It’s really, really hard. I just want to say thanks for all that you have accomplished, Relentless Health Value (RHV) tribe members…

1
Opioid Epidemic: Michael Barnes on the Fight to End the Crisis 51:45

5d ago51:45

51:45

In this episode, Ian Wendt and Dr. Na-Ri Oh interview Michael C. Barnes, Chairman of the Center for US Policy, about the US opioid crisis. They discuss the evolution of US policy on opioids, the impact of the crisis on different communities, the role of legislation and harm reduction, the accountability of the pharmaceutical industry, barriers to a…

1
Health Care–Related Savings Accounts, Health Care Expenditures, and Tax Expenditures 14:27

8d ago14:27

14:27

JAMA Health Forum Editor John Ayanian, MD, MPP, and Deputy Editor Melinda Buntin, PhD, spoke with Sherry Glied, PhD, and Dong Ding, MA, MPA, of New York University, about the effects of participation in health care savings accounts. Participation in flexible spending accounts is linked to higher health care and tax expenditures, while health care s…

1
EP450: When Your Health Plan Is $9 Million in the Hole, Who Are You Going to Call? A CPA. And Tell Them to Bring Their Spreadsheets, With Marilyn Bartlett, CPA, CGMA, CMA, CFM 34:45

9d ago34:45

34:45

In Episode 450 I speak with Marilyn Bartlett, a renowned CPA in the healthcare field, about her remarkable achievement of transforming the state of Montana’s employee health plan from $9 million in debt to a surplus of $112 million within three years. You can read the full show notes with mentioned links on the epsiode page. If you enjoy this podca…

1
CRISPR Gene-Editing Therapy 3:35

11d ago3:35

3:35

Send us a text Introduction to Gene-Editing Therapy: CRISPR CRISPR is a relatively new medical advancement that was inspired by the natural defense mechanism found in some microbes, such as bacteria. To protect themselves against invaders like viruses, these microbes capture snippets of the intruder’s DNA and store them away as segments called CRIS…

1
EP449: For Clinical Leaders, Payers, and Plan Sponsors, Let’s Talk About Blind Spots for Getting Patients or Members Appropriate Care, With Marty Makary, MD, MPH 38:07

16d ago38:07

38:07

So, I had a chance to read Dr. Marty Makary’s new book, which is called Blind Spots; and here’s why I wanted to get him to come back on Relentless Health Value and talk to you, people of the healthcare industry. It’s because of something that he said on page 127 and which I’ve been mulling over for probably years, actually. To Read The Full Article…

1
Medical Affairs Reimagined: Danny McBryan on Shaping Pharma’s Future 49:16

19d ago49:16

49:16

Danny McBryan, an executive leader in the pharmaceutical industry, discusses the evolving role of medical affairs in healthcare. He highlights the importance of medical affairs in conveying the science of pharmaceutical companies and translating complex data into a meaningful narrative for healthcare providers, payers, patients, and policymakers. M…

1
EP448 (Part 1): 340B: Where It Started, Where It Is Now, and Who Is Really Benefiting From This Massive Program, With Shawn Gremminger 37:57

23d ago37:57

37:57

So, after some pondering, I decided to release this conversation with Shawn Gremminger about 340B in two parts. So, listen to one, listen to both, pick your poison. Shawn Gremminger came up with three really important takeaways relative to 340B, which is a feat unto itself, considering how sprawling this conversation can be. So, if you came here fo…

1
Inside 340B Report Trailer 2:08

25d ago2:08

2:08

Inside 340B Report is your exclusive, behind-the-scenes window into the latest news and developments in the 340B drug pricing program, straight from the journalists at 340B Report. Each episode, published twice a month, brings listeners inside 340B Report’s newsroom for a candid, insider’s perspective on the evolving drug pricing policy landscape f…

1
Ep 52 | 340B Smorgasbord - Contract Pharmacy Legislation, ADR, Section 1115 Waiver Days & 340B Rebate Models 1:15:32

25d ago1:15:32

1:15:32

In this episode, Greg and Rob are joined by healthcare attorney and 340B veteran Barbara Straub Williams. They cover a variety of topics, including an update on litigation targeting state-level contract pharmacy laws (21:18), navigating manufacturer audits and ADR claim submissions (38:47), a recent court ruling related to exclusion of Section 1115…

1
Introduction to Targeted Therapies: CAR T-cell Therapy 3:30

25d ago3:30

3:30

Send us a text Introduction to Targeted Therapies: CAR T-cell Therapy T-cell Transfer Therapy is a special type of immunotherapy that takes a person’s own T-cells (a type of immune cell), adds specific antigens to the T-cells that can identify the cancer cells, and puts them back into the person’s body. Cancer cells express unique antigens (signali…

1
The Euphemism That Has Become Value-Based Care, With Elizabeth Mitchell—Summer Shorts 9 17:14

30d ago17:14

17:14

In this Summer Short Episode of Relentlessly Seeking Value, host Stacey Richter discusses the hidden costs and inefficiencies of value-based care with Elizabeth Mitchell, President and CEO of the Purchaser Business Group on Health (PBGH). To read the full article and show notes which include mentioned links, visit the episode page. If you enjoy thi…

1
Empowering the Patient Voice: A Deep Dive into Advocacy with Stacey Tinianov 49:26

1M ago49:26

49:26

In this episode, Na-Ri and Ian interview Stacey Tinianov, an independent patient advocate and founder of Advocates for Collaborative Education. They discuss the importance of patient advocacy, the role of digital health, and the future of patient engagement. Stacey shares her personal journey into patient advocacy and highlights the gaps in knowled…

1
Benefits of auditing every NDC and dispense every month 4:11

1M ago4:11

4:11

بقلم Stuart Murray

1
Encore! EP413: The Intersection of Healthcare Waste, Value-Based Care, and the Potential Rising Power of PCPs, With Will Shrank, MD 34:41

1M ago34:41

34:41

My conversation today is with Will Shrank, MD. Dr. Shrank led the evaluation group at CMMI (Center for Medicare and Medicaid Innovation). He has spent time in the private sector, first at CVS Health and UPMC (University of Pittsburgh Medical Center) as chief medical officer of the health plan in Pittsburgh, and then as the chief medical officer for…

1
Ep 51 | CMS Medicaid Drug Rebate Program & “Covered Outpatient Drug” Definition 1:17:32

1M ago1:17:32

1:17:32

In this episode, Greg and Rob are joined by healthcare attorney Todd Nova to discuss a proposed rule change put forth by CMS in 2023 regarding the Medicaid Drug Rebate Program (MDRP), which includes a potential change to the definition of “covered outpatient drug”. They’ll discuss how covered entities have historically interpreted the definition of…

1
Provider Insights on the Impact of 340B Pricing 3:54

1M ago3:54

3:54

Send us a text Provider Insights on the Impact of 340B Pricing. We frequently get asked for insights on how the 340B Drug Pricing Program may... or may not... be impacting the prescribing choices of participating covered entities. The Health Resources and Services Administration (HRSA) administers this federal program which is intended to help safe…

1
How Must Hospitals Recertify Their 340B Eligibility? 17:26

1M ago17:26

17:26

This marks the time of year when 340B hospitals complete the recertification process to maintain their eligibility for 340B. But why is this recertification needed, and what do hospitals need to know before undergoing recertification? Steven Miller, the vice president of pharmacy services for 340B Health, describes what is at stake when it comes to…

1
Encore! EP402: What Physicians Trying to Clinically Integrate Care in the Real World Need to Know, With Amy Scanlan, MD 32:50

1M ago32:50

32:50

This encore episode is with Amy Scanlan, MD. It was, in fact, one of our most popular episodes of the past year. It is still just as relevant today in a slightly different way. It’s interesting how things which were said maybe a year ago have shades of meaning which become evident as time goes on. So, I liked this show a lot in the second listen wi…

1
Interview with Optimal 340B: Navigating the Complexities Operational Challenges in the 340B Program 7:48

2M ago7:48

7:48

This is an interview with Lyssa Limbrecht-Moss, founder and CEO or Optimal 340B, on the complexities and operational challenges in the 340B program.بقلم Stuart Murray and Lyssa Limbrecht-Moss

1
AI Revolution: Transforming Biopharma with Andree Bates 51:28

2M ago51:28

51:28

Summary Dr. Andrée Bates, a pioneering force in the realm of artificial intelligence within the pharmaceutical industry, shares insights on the evolving role of AI in pharma, the future of healthcare innovation, and her advocacy for women in leadership. She discusses the early days of AI in pharma, the challenges faced, and the evolution of AI term…

1
EP447: Why an “EHR Strategy” Isn’t Enough, With Ashleigh Gunter 28:44

2M ago28:44

28:44

In Episode 447, Stacey Richter interviews Ashleigh Gunter, president of Translucent Healthcare Consulting, to discuss the indispensable role of change management in healthcare transformation. They emphasize that creating an effective change strategy involves great leadership, a clear case for change, influential change champions, over-communication…

1
Tips on finding bad multipliers 2:57

2M ago2:57

2:57

Short episode on how to use your TPA web portal to find bad multipliers (conversion factors).بقلم Stuart Murray

1
Ep 50 | 340B Q&A with Hoopii 46:34

2M ago46:34

46:34

This is our 50th episode, and it marks the 2 year anniversary of the 340B Unscripted Podcast. To mark the occasion, Greg asks Rob a hodgepodge of 340B-related questions including entity-owned vs contract pharmacy considerations, out-of-state Medicaid carve-out challenges, “class of trade”, referral capture documentation standards and how CEs should…

1
Quickly recover lost savings 2:34

2M ago2:34

2:34

Learn how to quickly recover thousands of dollars, even hundreds of thousands, in lost savings!بقلم Stuart Murray

1
The Federal NOPAIN Act 3:19

2M ago3:19

3:19

Send us a text Today’s topic is the The Federal NOPAIN Act. The Federal “Non-Opioids Prevent Addiction In the Nation Act” (or, the “NOPAIN Act”), Senate bill S.586, was signed into law in December 2022. It takes effect this coming January as part of the Centers for Medicare and Medicaid Services 2025 OPPS proposed rule. The NOPAIN Act directs CMS t…

1
What Role Can AI Play in 340B? 15:46

2M ago15:46

15:46

Artificial intelligence is a hot topic in 2024. Discussions about AI in health care continue to grow, including about the potential for such technology to improve care and save lives. What role might AI play in the 340B world? We speak with WVU Medicine Enterprise 340B Program Coordinator Elizabeth Gibson to learn how one health system is exploring…

1
EP446: Hey, Let’s Not Talk About EHRs, With Spencer Dorn, MD, MPH, MHA 34:37

2M ago34:37

34:37

In Episode 446, "Hey, Let's Not Talk About EHRs," host Stacey Richter engages Dr. Spencer Dorn, vice chair and professor of medicine at the University of North Carolina, in a comprehensive discussion about the implications of healthcare technology, specifically electronic health records (EHRs). Visit the Episode Page to read the show notes with men…

1
Unveiling UW Medicine's 340B Impact: A Conversation with Sumona Das Gupta 14:17

2M ago14:17

14:17

In this episode of the 340B Insider podcast, Sumona discusses UW Medicine's new initiative to highlight the impact of the 340B program and share the multifaceted benefits of 340B in enhancing patient care and community health. She explains how the initiative was structured, the role of the 340B oversight committee, and the importance of creating a …

1
Unmasking PBMs: Antonio Ciaccia Exposes the Hidden Power Players in Healthcare 57:27

2M ago57:27

57:27

Summary In this episode, Dr. Na-Ri Oh and Ian Wendt discuss Pharmacy Benefit Managers (PBMs) and their impact on drug pricing and patient access to medications. They are joined by Antonio Ciaccia, CEO of 46 Brooklyn Research and president of 3 Access Advisors, which provides insights into the role of PBMs in the drug supply chain. The conversation …

1
Highlights From the AcademyHealth 2024 Annual Research Meeting 17:12

2M ago17:12

17:12

AcademyHealth CEO Aaron Carroll, MD, MS, shares highlights from the AcademyHealth 2024 Annual Research Meeting in an interview hosted by JAMA Health Forum Editor John Ayanian, MD, MPP, and Deputy Editor Melinda Buntin, PhD. John and Melinda then discuss key findings from 4 highly rated abstracts presented at the meeting that were published concurre…

1
EP445: Can a Primary-Care-Only Practice Survive in 2024? With Tom X. Lee, MD 47:53

2M ago47:53

47:53

I wanted to talk with Dr. Lee because so many RHV (Relentless Health Value) listeners are trying to figure out how to sustain primary care as a stand-alone entity when the most obvious and most common way to make enough money in primary care is to drive and maximize the dollars from downstream volume of high-priced service lines, which, if you thin…

1
High Value Pharmacy Enterprise Framework 4:23

2M ago4:23

4:23

Send us a text The High-Value Pharmacy Enterprise Framework. The High-Value Pharmacy Enterprise Framework is a collection of evidence-based and expert recommended best practices designed to enhance health system pharmacy operations by ensuring safe, effective, and patient-centered medication management throughout the health-system pharmacy enterpri…

1
What Are the Keys To Enacting State 340B Protections? 20:49

2M ago20:49

20:49

We have released several episodes in recent months in which we have discussed federal and state legislative efforts on 340B. But what does it take to get 340B protections through a state legislature and to the governor’s desk? In this episode, we speak with Ryan Cross, vice president of governmental affairs with Franciscan Missionaries of Our Lady …

1
Ep 49 | HRSA Audit Trends and Manufacturer Audit Activity – Conversation with Emily Cook 1:05:53

2M ago1:05:53

1:05:53

In this episode, Greg and Rob have another repeat guest! Healthcare attorney Emily Cook shares some insights gained from the 340B Coalition Summer Conference around recent HRSA audit patterns (08:37) and a cluster of manufacturer audits of 340B covered entities (27:46). In the intro, the guys touch base on some 340B newsworthy developments in the c…

المدونة الصوتية تستحق الاستماع

340B بودكاست

المدونة الصوتية تستحق الاستماع

دليل مرجعي سريع